Global Nasal Polyps Treatment Market Report 2024

Nasal Polyps Treatment Global Market Report 2023 – By Type (Pharmacological Therapies, Surgeries), By Route (Oral, Nasal, Other Routes), By Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Nasal Polyps Treatment Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Nasal polyps are soft, painless, noncancerous growths on the lining of your nasal passages or sinuses. They dangle like grapes or teardrops and are linked with asthma, persistent infections, allergies, medication sensitivity, and other immunological disorders.

The nasal polyps treatment market consists of sales of nasal polyps treatment by entities (organizations, sole traders, and partnerships) that are used for the treatment of nasal polyps which shrink or disrepair the nasal polyps. Nasal polyps are soft, painless noncancerous growths on the lining of your nasal passages or sinuses. They dangle like grapes or teardrops and are linked with asthma, persistent infection, allergies, medication sensitivity, and other immunological disorders.

The main types of nasal polyps treatment are pharmacological therapies and surgeries. Pharmacological therapies refers to the use of medication to treat a disorder or disease. In the treatment of addiction, medications are used to reduce withdrawal symptoms, decrease alcohol and other drug cravings, and reduce the likelihood of relapse. The various routes nasal polyps treatment administration include oral, nasal, and others. These are distributed among hospital pharmacies, retail pharmacies, and online pharmacies.

The global nasal polyps treatment market is segmented -

1) By Type: Pharmacological Therapies, Surgeries

2) By Route: Oral, Nasal, Other Routes

3) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The global nasal polyps treatment market size grew from $4.36 billion in 2022 to $4.72 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nasal polyps treatment market size is expected to grow to $6.35 billion in 2027 at a CAGR of 7.7%.

Developing novel approaches for the treatment of nasal polyps is expected to drive the nasal polyps treatment market going forward. Nasal polyps are a multifactorial syndrome that's linked to a variety of diseases and pathogenic disorders, including allergies, infections, allergic fungal sinusitis, cystic fibrosis, asthma, and aspirin intolerance. Hence, pharmaceutical companies are developing new and novel approaches for its treatment. For instance, in July 2020, GlaxoSmithKline plc (GSK), a UK-based pharmaceutical and biotechnology company, announced that IL-5-targeting monoclonal antibody Nucala (mepolizumab) has been approved by the US Food and Drug Administration (FDA) as a treatment for people with chronic rhinosinusitis with nasal polyps. Adult patients who did not reacted well to nasal corticosteroids used mepolizumab as a maintenance treatment for CRSwNP. Therefore, the development of novel approaches for the treatment of nasal polyps is expected to boost demand for the nasal polyps treatment during the forecast period.

Major players in the nasal polyps treatment market are Sanofi S.A., GlaxoSmithKline PLC, F. Hoffmann La Roche AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Novartis International AG, OptiNose US Inc., Regeneron Pharmaceuticals Inc., Intersect ENT Inc., and AstraZeneca PLC.

New product innovation is a key trend gaining popularity in nasal polyps treatment. Major companies operating in the nasal polyps treatment market are focusing on new product innovations to strengthen their position in the market. For instance, in July 2021, GlaxoSmithKline PLC., a UK-based pharmaceutical company, announced the approval for Nucala (mepolizumab) by US Food and Drug Administration (FDA). Nucala (mepolizumab) is a monoclonal antibody that targets interleukin-5 (IL-5) and is a treatment for patients with chronic rhinosinusitis and nasal polyps. This new indication for mepolizumab is for the maintenance treatment of CRSwNP in adult patients aged 18 and up who have not responded to nasal corticosteroids.

In September 2021, Merck & Co. Inc., a US-based biopharmaceutical company, acquired Acceleron Pharma Inc. for a deal amount of $11.5 billion. With this acquisition, Acceleron researchers aim to leverage decades of scientific expertise in the biology of the TGF-beta superfamily to create a powerful biotechnology product. Acceleron is a US-based biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases including nasal polyps treatment therapies.

North America was the largest region in the nasal polyps treatment market in 2022 Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal polyps treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the nasal polyps treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The nasal polyps treatment market includes revenues earned by entities by nasal corticosteroids, oral and injectable corticosteroids, and other medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The nasal polyps treatment market research report is one of a series of new reports from The Business Research Company that provides nasal polyps treatment market statistics, including nasal polyps treatment industry global market size, regional shares, competitors with a nasal polyps treatment market share, detailed nasal polyps treatment market segments, market trends and opportunities, and any further data you may need to thrive in the nasal polyps treatment industry. This nasal polyps treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Nasal Polyps Treatment Market Characteristics

    3. Nasal Polyps Treatment Market Trends And Strategies

    4. Nasal Polyps Treatment Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Nasal Polyps Treatment Market

    4.2 Ukraine-Russia War Impact On Nasal Polyps Treatment Market

    4.3 Impact Of High Inflation On Nasal Polyps Treatment Market

    5. Nasal Polyps Treatment Market Size And Growth

    5.1. Global Nasal Polyps Treatment Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Nasal Polyps Treatment Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Nasal Polyps Treatment Market Segmentation

    6.1. Global Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Pharmacological Therapies

    Surgeries

    6.2. Global Nasal Polyps Treatment Market, Segmentation By Route, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oral

    Nasal

    Other Routes  

    6.3. Global Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Nasal Polyps Treatment Market Regional And Country Analysis

    7.1. Global Nasal Polyps Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Nasal Polyps Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Nasal Polyps Treatment Market

    8.1. Asia-Pacific Nasal Polyps Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Nasal Polyps Treatment Market

    9.1. China Nasal Polyps Treatment Market Overview

    9.2. China Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Nasal Polyps Treatment Market

    10.1. India Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Nasal Polyps Treatment Market

    11.1. Japan Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Nasal Polyps Treatment Market

    12.1. Australia Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Nasal Polyps Treatment Market

    13.1. Indonesia Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Nasal Polyps Treatment Market

    14.1. South Korea Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Nasal Polyps Treatment Market

    15.1. Western Europe Nasal Polyps Treatment Market Overview

    15.2. Western Europe Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Nasal Polyps Treatment Market

    16.1. UK Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Nasal Polyps Treatment Market

    17.1. Germany Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Nasal Polyps Treatment Market

    18.4. France Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Nasal Polyps Treatment Market

    19.1. Eastern Europe Nasal Polyps Treatment Market Overview

    19.2. Eastern Europe Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Nasal Polyps Treatment Market

    20.1. Russia Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Nasal Polyps Treatment Market

    21.1. North America Nasal Polyps Treatment Market Overview

    21.2. North America Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Nasal Polyps Treatment Market

    22.1. USA Nasal Polyps Treatment Market Overview

    22.2. USA Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Nasal Polyps Treatment Market

    23.1. South America Nasal Polyps Treatment Market Overview

    23.2. South America Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Nasal Polyps Treatment Market

    24.1. Brazil Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Nasal Polyps Treatment Market

    25.1. Middle East Nasal Polyps Treatment Market Overview

    25.2. Middle East Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Nasal Polyps Treatment Market

    26.1. Africa Nasal Polyps Treatment Market Overview

    26.2. Africa Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Nasal Polyps Treatment Market Competitive Landscape And Company Profiles

    27.1. Nasal Polyps Treatment Market Competitive Landscape

    27.2. Nasal Polyps Treatment Market Company Profiles

    27.2.1. Sanofi S.A

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. GlaxosmithKline Plc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. F. Hoffmann La Roche AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck & Co Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Teva Pharmaceutical Industries Ltd.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Nasal Polyps Treatment Market

    29. Nasal Polyps Treatment Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer  

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Nasal Polyps Treatment Market, Segmentation By Route, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Nasal Polyps Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Nasal Polyps Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Sanofi S.A Financial Performance
  • Table 47: GlaxosmithKline PLC. Financial Performance
  • Table 48: F. Hoffmann La Roche AG Financial Performance
  • Table 49: Merck & Co Inc. Financial Performance
  • Table 50: Teva Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Nasal Polyps Treatment Market, Segmentation By Route, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Nasal Polyps Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Nasal Polyps Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Nasal Polyps Treatment Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Nasal Polyps Treatment Market, Segmentation By Distribution, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Sanofi S.A Financial Performance
  • Figure 47: GlaxosmithKline PLC. Financial Performance
  • Figure 48: F. Hoffmann La Roche AG Financial Performance
  • Figure 49: Merck & Co Inc. Financial Performance
  • Figure 50: Teva Pharmaceutical Industries Ltd. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report